EMA — authorised 20 February 2023
- Marketing authorisation holder: ASTRAZENECA AB
- Status: approved
🇪🇺 Imjudo in European Union
EMA authorised Imjudo on 20 February 2023
Marketing authorisation
Imjudo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Imjudo approved in European Union?
Yes. EMA authorised it on 20 February 2023.
Who is the marketing authorisation holder for Imjudo in European Union?
ASTRAZENECA AB holds the EU marketing authorisation.